Emergency contraception in the iPLEDGE program: A cross-sectional survey of pediatric dermatology provider understanding and practice

Catherine E. Smiley, Melissa Butt, Andrea L. Zaenglein

Research output: Contribution to journalArticlepeer-review

Abstract

For patients with acne treated with the teratogen isotretinoin, emergency contraception (EC) is the only recourse when abstinence fails or effective contraception is not properly used. The purpose of this study was to evaluate the current understanding and provision of EC among pediatric dermatology providers. The survey found that 37% (21/57) of providers indicated they were at least somewhat confident in their understanding of EC. 7% (4/57) of providers agreed/strongly agreed that they provided EC counseling to all patients of reproductive potential at their initial visit and 3.5% (2/57) agreed/strongly agreed that they provide EC counseling at follow-up visits. Our survey results suggest the need for improved EC education for pediatric dermatology providers and subsequent counseling for patients of reproductive potential on isotretinoin therapy.

Original languageEnglish (US)
Pages (from-to)727-730
Number of pages4
JournalPediatric dermatology
Volume39
Issue number5
DOIs
StatePublished - Sep 1 2022

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Dermatology

Fingerprint

Dive into the research topics of 'Emergency contraception in the iPLEDGE program: A cross-sectional survey of pediatric dermatology provider understanding and practice'. Together they form a unique fingerprint.

Cite this